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Abstract
Background Lipid disorders are known to be linked to
disturbance in oxidative reactions and play an important
role in the progression and complications of idiopathic
nephrotic syndrome (INS).
Aims The aim of this study was to assess oxidized low-
density lipoprotein (oxLDL), high-sensitive C-reactive
protein (hs-CRP) serum concentrations and other parame-
ters of lipid metabolism in children with INS during relapse
and remission of proteinuria.
Methods The examination was performed on 23 children
and adolescents diagnosed with INS. Reference group
consisted of 22 participants. The study was carried out
twice: in the relapse of INS (A) and in remission of pro-
teinuria during glucocorticoid treatment (B).
Results OxLDL was higher in INS patients, in both
examinations when compared with reference participants.
hs-CRP showed no differences between nephrotic and
healthy children. We found higher concentration of oxLDL
in children, who where frequent relapsers. Cholesterol,
triglycerides/high density lipoprotein cholesterol and
platelets were higher in INS patients (both A and B) in
comparison with healthy children.
Conclusions We observed presence of pro-atherogenic
lipid profile in INS. Elevation of oxLDL may reflect
increased oxidative stress and higher risk of atherosclerosis
in INS, therefore it seems to be relevant to find patients of
risk of atherosclerosis to consider lipid lowering treatment
with antioxidants.
Keywords Idiopathic nephrotic syndrome 
Oxidative stress  Atherosclerosis  OxLDL  hs-CRP
Introduction
Oxidative stress (OS), defined as disturbance in the reactive
oxygen species (ROS) and antioxidant balance, can result
either from low levels of antioxidants and/or from an.
increased production of ROS. Oxidative stress has been
previously demonstrated in various kidney disorders such
as glomerulonephritis [1] and acute renal injury [2] or
diabetic nephropathy [3]. Experimental studies showed that
ROS also play an important role in the pathogenesis of
experimental puromycin aminonucleoside induced
nephrosis [4]. It has been postulated that childhood idio-
pathic nephrotic syndrome (INS) is associated with OS due
to increased levels of ROS and decreased levels of anti-
oxidants [5]. Mishra et al. [2] reported evidence of OS and
impaired antioxidant defense during acute INS. Previous
studies have demonstrated presence of oxidative stress in
children with idiopathic nephrotic syndrome, but there is
paucity of data regarding its status among different sub-
groups of patients [6–8]. An important advance in under-
standing the pathogenesis of INS was the observation that
oxygen-free radicals are possible mediators of injury in
experimental nephrosis in rats. The similarity of that ani-
mal model to human minimal change nephrotic syndrome
(MCNS) provokes the idea that free-radical mediated
injury could play a role in the pathogenesis of that disorder
[9]. This is probably a consequence of an imbalance
between oxidant and antioxidant activity in vivo [10].
Furthermore, dyslipidemia in INS is also known to be
linked to oxidative reactions and atherosclerosis [11].
Patients with INS have elevated concentrations of total
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cholesterol (TC), LDL cholesterol (LDL-C), and triglyc-
erides (TG), whereas, HDL cholesterol (HDL-C) has var-
iously been reported to be increased, decreased, or normal
[5]. Lipoproteins: Lp(a), ox-Lp(a) and Lp(a)-IC levels were
increased in INS children, which may play an important
role in the processes of atherosclerosis [12]. These abnor-
malities suggest that nephrotic patients have higher risk of
developing atherosclerosis.
In the last three decades, a large volume of studies have
established that oxidized low-density lipoprotein (oxLDL)
is a useful marker of cardiovascular diseases (CVDs) [12,
13]. The measurement of oxLDL correlates with the pre-
sence of CVDs and indicates that oxLDL is a potential
prognostic indicator for future health events. OxLDL is
known to stimulate macrophages to induce foam cell for-
mation and inflammatory responses. We read with a great
interest paper of Zhang et al. [14], who found a positive
significant correlation between oxLDL and C-reactive
protein (CRP) in patients with acute coronary syndrome
(ACS). This study brings new insights that oxLDL and
CRP may play a direct role in promoting the inflammatory
component of atherosclerosis.
The aim of this study was to assess oxLDL and hs-CRP
serum concentrations in children with INS.
Methods
Written informed consent was obtained from parents and
all participants older than 16 years old. The protocol was
approved by the Bioethics Committee of the Medical
University of Bialystok in accordance with the Declaration
of Helsinki.
The examination was performed on a group of 23 chil-
dren and adolescents diagnosed with INS according to the
definition of the International Society of Kidney Disease in
Children [15], treated in the Department of Pediatrics and
Nephrology, in years 2011–2012. All nephrotic patients
who fulfilled the inclusion criteria were included in the
study. Inclusion criteria were: steroid-sensitive nephrotic
syndrome (SSNS), age at the time of the study
(1.8–18 years), normal blood pressure during examination,
normal GFR ([90 ml/min/1.73 m2), according to Schwartz
formula, absence of clinical and laboratory findings of a
systemic disease, accomplishing the criteria of a relapse of
NS. Exclusion criteria: signs of an acute infection (body
temperature [37 C), presence of other chronic diseases,
immunosuppressive treatment other than glucocorticoids
(GCS) therapy.
The testing was performed twice: A, in relapse of NS,
before starting GCS therapy and B, in remission of pro-
teinuria (at least 3 days without proteinuria in urinalysis),
during GCS treatment. All participants with INS were
treated with the standard GCS initial therapy—daily dos-
age of prednisone 60 mg/m2 body surface area for
4 weeks, followed by 40 mg/m2 given on alternate days,
followed by various tapering on alternate days. Relapses
were treated with daily prednisone 60 mg/m2 until remis-
sion was achieved, followed by 40 mg/m2 on alternate
days.
Reference group consisted of 22 healthy children and
adolescents (M: 11, F: 11), aged 0.7–18 years, diagnosed in
our Department because of monosymptomatic nocturnal
enuresis. They did not have any signs of acute or chronic
disease and did not take any drugs. Some participants were
also healthy children of the personnel working in the
Department. Health status was determined through the
subjects’ medical history, parental report and routine lab-
oratory tests.
All samples were collected after 12 h of night fasting.
Blood samples were drawn to measure serum concentra-
tions of: oxLDL, hs-CRP, albumin, total cholesterol, LDL
cholesterol, HDL cholesterol, triglycerides and platelets
count. For the purpose of the assay 650 ll of sera was
obtained from residual blood sample. Serum samples were
stored at -80 C until assayed.
Urinalysis was performed to assess protein level in the
morning sample. Both oxLDL and hs-CRP serum con-
centrations were determined using ELISA method,
according to the instruction given by the manufacturer
(oxLDL ELISA Kit, Immunodiagnostik AG, hs-CRP—
LDN Labor Diagnostika Nord GmbH & Co.KG). The
detection limit of oxLDL and hs-CRP were 4.13 and 10 ng/
ml, respectively. The intra and inter-assay coefficients of
variation (CV) for both of them were: 3.9 and 11 % for
oxLDL and 15.2 and 9.9 % for hs-CRP.
The data were analyzed using the Statistica 10.0 pack-
age. Adequacy of parameters to normal distribution was
tested by using Shapiro–Wilk Test. The Mann–Whitney
U test was used to compare independent data when the
variables did not follow a normal distribution. Correlations
between clinical and laboratory parameters were tested by
Spearman correlation coefficients. Chi-square test was used
for categorical variables. Multiple regression model was
created for the oxLDL as a dependent variable. Value of
p\ 0.05 was considered statistically significant.
Results
Table 1 shows characteristics of examined subjects in
relapse of INS (A), after resolution of proteinuria (B) and
reference group (R). Children with INS were in similar age
as reference participants. The proportion of male was
greater in nephrotic children what is consistent with the
demographics of childhood INS [16].
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We found significantly higher serum concentration of
TC, LDL-C and TG (p\ 0.01) as well as HDL-C
(p\ 0.05) in nephrotic children in comparison with ref-
erence subjects. In INS patients we did not observe any
significant decrease of serum levels of these biochemical
parameters in examination B.
Nephrotic patients (group A and B) had also much
higher platelets count (PLT) in comparison with reference
group (p\ 0.01). Obviously albumin concentration was
much lower in INS participants before treatment (group A)
in comparison with both INS patients after resolution of
proteinuria (p\ 0.01) and reference children (p\ 0.01).
OxLDL concentration was significantly higher in children
with INS, both group A and B in comparison with refer-
ence group (p\ 0.05) Fig. 1, while serum hs-CRP showed
no statistically significant differences between children
with INS and reference group. Atherogenic index—TG/
HDL-C—was significantly higher in INS patients, both
before and during GCS treatment (p\ 0.01). We also
analyzed oxLDL concentration in nephrotic patients in
relation to the number of relapses. We found significantly
higher concentration of oxLDL in children who where
frequent relapsers (p\ 0.01).
We assessed correlations between examined markers
(oxLDL, hs-CRP) and other biochemical parameters in all
examined children.
Table 1 Clinical and metabolic characteristics of subjects entered the study and the reference group
Variable A (relapse with proteinuria) B (relapse without proteinuria) R (reference group) p
*AvB
**AvR
Age (years) 4 (1.8–18) 4 (1.8–18) 5.75 (0.7–18) *NS
**NS
Sex (M/F) (%M) 15/8 (65.2 %) 15/8 (65.2 %) 11/11 (50 %) *NS
**NS
Albumin (g/l) 1.82 (0.98–3.1) 2.79 (1.89–3.62) 4.83 (3.9–4.83) *\0.01
**\0.01
Cholesterol (mg/dl) 376 (185–724) 352 (166–495) 170 (106–203) *NS
**\0.01
HDL-C (mg/dl) 77 (32–116) 76.5 (26–314) 55 (26–77) *NS
**\0.05
Triglycerides (mg/dl) 259 (69–377) 205.5 (123–351) 68.5 (53–115) *NS
**\0.01
TG/HDL ratio 3.99 (0.76–8.32) 2.5 (0.68–7.89) 1.48 (0.69–3.1) *NS
**\0.01
Patelets count (9103/mm3) 390 (199–920) 421 (270–780) 220 (149–456) *NS
**\ 0.01
hs-CRP (mg/l) 2.97 (1.08–84.67) 3.76 (1.16–98.5) 3.01 (1.16–8.22) *NS
**NS
OxLDL (ng/ml) 357.19 (40–2,500) 320.8 (23.01–2,500) 85.5 (40–572.91) *NS
**\0.05
All values are median and range, unless otherwise noted
HDL-C high density lipoprotein cholesterol, TG/HDL triglicerides/high density lipoprotein cholesterol, hs-CRP high sensitive C-reactive protein,
























A - INS in the relapse, B - after resolution of proteinuria, R - reference group
*NS
**p<0.05
Fig. 1 Comparison of oxLDL serum concentrations between studied
groups
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There were positive correlations between: oxLDL and
PLT count (r = 0.26, p\ 0.05), oxLDL and TG (r = 0.36,
p\ 0.05), oxLDL and TG/HDL ratio (r = 0.53, p\ 0.05)
and oxLDL and hs-CRP (r = 0.31, p\ 0.05). The factors
that were found to have significant correlation with oxLDL
serum concentration in the single regression analyzes were
used as explanatory variables to create the multiple
regression model. To reduce the impact of multicollinearity
we removed some correlated variables. In the model,
remaining parameters (hs-CRP, PLT count and TG/HDL
ratio) accounted for more than 33 % of the variations in
oxLDL level (r = 0.51, p\ 0.01); Table 2.
We also observed positive correlation between hs-CRP
and TG/HDL ratio (r = 0.37, p\ 0.05) and negative cor-
relation between hs-CRP and HDL-C (r = -0.38,
p\ 0.05). Neither oxLDL nor hs-CRP correlated with
serum albumin or proteinuria.
Discussion
In this cross-sectional study we evaluated serum concen-
trations of oxLDL and hs-CRP in patients with INS and
assessed correlation between these parameters and other
markers of atherosclerosis. The lipids profile of INS
patients revealed a typical pattern with elevated serum
concentration of TC, LDL-C, TG. We also found signifi-
cant hypoalbuminemia in INS children. There were sig-
nificantly higher oxLDL values in nephrotic children in
comparison to healthy subjects. We observed significantly
higher concentration of oxLDL in children who where
frequent relapsers irrespectively of a current relapse
treatment.
Laboratory, clinical and pathological findings of the last
decades proved that atherosclerosis is a process beginning
in early childhood and progressing into adulthood [17]. Its
main result is a great risk of coronary heart disease. It is
obvious that high serum cholesterol level in childhood
increases the risk of developing atherosclerosis in adults.
Young patients with INS are more endangered with car-
diovascular disease because of hyper- and dyslipidemia.
However, it is considered that the risk of fast progression of
atherosclerosis in nephrotic patients with good response to
GCS therapy seems to be minimal, because the state of
hypercholesterolemia is of short duration and intermittent.
The most endangered group of patients with NS are those
with unremitting proteinuria, frequent relapses and/or poor
response to GCS and long standing hypoalbuminemia [18].
Hyper- and dyslipidemia are one of the most typical
features of NS, with elevated serum levels of TC, LDL-C,
TG and usually decreased HDL-C. This pro-atherogenic
profile of lipids existing in NS is, in connection with lipid
peroxidation, responsible for initial glomerular injury as
well [19]. An escalation of lipid peroxidation and the
release of free radicals (ROS) being strong oxidants result
in glomerular injury and proteinuria [20]. They disrupt the
integrity of membrane filtration barrier and impair capillary
walls [21].
Observations of the last few years suggested that oxLDL
may play an important role not only in the formation of
atherosclerotic lesions but also in the progression of glo-
merulosclerosis [12, 22]. OxLDL enhances the expression
of proinflammatory genes and recruits monocytes into
vessel walls [23]. It acts through inflammatory signaling
pathway CD40/CD40L and increases expression of matrix
metalloproteinases genes (MMP-1 and-3) in endothelium
[1, 2]. Its cytotoxic activity towards endothelium is related
to production of ROS and impairment of nitric oxidase
synthase gene as well [24]. Oxidative stress and increased
serum concentration of oxLDL are strong mitogens for
smooth muscles [25]. What is more, oxLDL particles are
taken up by macrophages that become foam cells—form-
ing fatty plaques in the tunica intima in arteries.
OxLDL serum concentration was higher in INS children
in comparison to reference group. Nagla et al. who
examined oxidative modification of LDL in 40 children
with steroid sensitive nephrotic syndrome, also found sig-
nificantly higher serum levels of oxLDL in this group of
children in comparison with healthy volunteers, with
especially high values in relapse group [12].
We found significantly higher concentration of oxLDL
in children being frequent relapsers (more than 2 relapses
of NS), irrespectively of presence of proteinuria. It seems
that presence of proteinuria during relapse is not the main
factor of increased risk of developing atherosclerosis. Also
lack of correlation between oxLDL and proteinuria or
serum albumin may confirm this thesis. Results of our
investigation suggest that serum oxLDL concentration may
be especially increased in INS patients with multiple
relapses. Because of frequent, long standing proteinuria
and dyslipidemia connected with toxic disturbances in
oxidative status, they have relatively higher risk of ath-
erosclerosis and elevated oxLDL may reflect this situation.
This observation is consistent with Lechner et al. [26] who
showed that long standing and frequently relapsing
nephrotic patients are those, who are more endangered with






hs-CRP 4.89 6.49 -8.31–18.09 0.46
PLT -0.38 0.48 -1.35–0.59 0.43
TG/HDL 126.56 55.31 14.03–239.08 0.03
hs-CRP high sensitive C-reactive protein, PLT platelets count,
TG/HDL triglicerides/high density lipoprotein cholesterol
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an increased risk of cardiovascular complications. In chil-
dren with minimal change nephrotic syndrome who are
steroid sensitive, the risk of premature atherosclerosis is
quite low. Glicocoticosteroids are not likely to have any
influence on oxLDL values—it was similar during relapse,
before treatment and similarly in the same children after
resolution of proteinuria. This is consistent with observation
of Nagla et al. [12] who did not find any normalization of
studied markers despite of use of GCS until remission of
proteinuria. What is more, there are some experimental
findings suggesting that GCS impairs antioxidant status and
stimulates production of ROS [27]. On the other hand the
study of Kawamura et al. [28] emphasized therapeutic role of
GCS therapy in stimulation of activity of antioxidant factors.
According to studies of last decades, inflammation is
another process playing a pivotal role in the development
and progression of atherosclerosis and cardiovascular dis-
ease [29]. Its main marker is an acute phase protein—C-
reactive protein (CRP). It was shown that even slightly
increased CRP serum concentration—detected as high-
sensitive CRP (hs-CRP)—is associated with increased risk
of atherothrombotic events in healthy participants. CRP is
able to bind directly to LDL-C particles, especially oxi-
dized (oxLDL) and is deposited in atheromathous plaques
[30]. Moreover, its proinflammatory properties further
stimulate progression of atheroma. However in our study
hs-CRP values did not differ between NS patients and
healthy volunteers. This observation is consistent with Ece
et al. [11] who tested anti-oxidant status in relation to pro-
inflammatory cytokines in INS children. Perhaps the pro-
inflammatory and proatherogenic role of hs-CRP is not as
important as escalating oxidative stress responsible for
lipids peroxidation and higher oxLDL values in frequently
relapsing nephrotic children.
Although we have not found any difference between hs-
CRP concentration in nephrotic and healthy children, we
noticed positive correlation between hs-CRP and approved
atherosclerosis indicator TG/HDL-C ratio in children with
relapse of INS after resolution of proteinuria. In studies of
Protasio Lemos da Luz et al. elevation in the TG/HDL-C
ratio is the most powerful predictor of coronary heart dis-
ease irrespectively of other lipid serum markers [31].We
also noticed positive correlation between oxLDL and two
approved atherosclerosis indicators hs-CRP and TG/HDL-
C ratio. Also Zhang et al. [14] confirmed positive corre-
lation between oxLDL and CRP in patients with acute
coronary syndrome.
Our observation showed significantly higher concentra-
tion of TG/HDL-C ratio in INS patients and elevated PLT
count in this group of children. Increased PLT count is
another factor of development of atherothrombosis. This
may confirm higher risk of atherosclerotic complications in
the course of INS especially in those children who are
steroid resistant and frequent relapsers and cannot achieve
long-lasting remission with normalization of dyslipidemia.
In conclusion, the results of this study confirm presence
of typical pro-atherogenic lipid profile in children with
INS. Elevation in oxLDL concentration in frequent
relapsers may reflect increased oxidative stress and higher
risk of atherosclerosis in these group of patients. GCS
therapy did not influence on concentration of pro-athero-
genic biochemical bionicles—therefore it seems to be rel-
evant to find patients of high risk of atherosclerosis and
CVD to consider lipid lowering treatment combined with
antioxidants. This study has some limitations. The main is
relatively small sample size. It seems to be relevant to
perform the examination on a larger group of patients. In
the future, participants should be sex matched more care-
fully. It might be interesting to enroll patients in remission
of INS, without GCS treatment. This could enable to draw
more obligatory conclusions.
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